Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
18.92
-2.62 (-12.16%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Cidara Therapeutics Employees
Cidara Therapeutics had 38 employees as of December 31, 2024. The number of employees decreased by 31 or -44.93% compared to the previous year.
Employees
38
Change (1Y)
-31
Growth (1Y)
-44.93%
Revenue / Employee
$33,553
Profits / Employee
-$4,469,132
Market Cap
207.24M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CDTX News
- 1 hour ago - Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 2 hours ago - Cidara Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 13 days ago - Cidara Therapeutics to Participate in World Health Organization Meeting on H5N1 Influenza Preparedness and Response - GlobeNewsWire
- 14 days ago - Cidara Therapeutics Announces Two Presentations on CD388 in Influenza at International Conference on Antiviral Research (ICAR) 2025 - GlobeNewsWire
- 15 days ago - Cidara Therapeutics Announces Publication of CD388 Preclinical Data in Nature Microbiology - GlobeNewsWire
- 26 days ago - Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer - GlobeNewsWire
- 7 weeks ago - Bullish On Cidara Therapeutics As It Doubles Down On CD388 For Universal Flu Prevention - Seeking Alpha